Shenzhen New Industries Biomedical (300832) — Financial Flexibility Index
Shenzhen New Industries Biomedical (300832) has a Financial Flexibility Index of 0.78x as of September 2025. Free cash flow of CN¥651.99 Million (operating CF CN¥606.21 Million minus capex CN¥45.78 Million) represents 1% of total liabilities (CN¥831.98 Million). Also explore Shenzhen New Industries Biomedical annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shenzhen New Industries Biomedical Financial Flexibility Index (2012–2024)
Historical Financial Flexibility Index trend for Shenzhen New Industries Biomedical across 13 annual periods. Check 300832 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Shenzhen New Industries Biomedical (2012–2024)
Year-by-year free cash flow to debt coverage for Shenzhen New Industries Biomedical. For the full company profile including market capitalisation, see Shenzhen New Industries Biomedical stock valuation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.72x | CN¥1.80 Billion | CN¥1.36 Billion | CN¥1.04 Billion | ▼ -32.9% |
| 2023 | 2.57x | CN¥1.74 Billion | CN¥1.42 Billion | CN¥678.09 Million | ▲ +15.6% |
| 2022 | 2.22x | CN¥1.37 Billion | CN¥962.39 Million | CN¥615.06 Million | ▲ +4.1% |
| 2021 | 2.13x | CN¥1.12 Billion | CN¥773.22 Million | CN¥523.51 Million | ▼ -13.2% |
| 2020 | 2.46x | CN¥1.23 Billion | CN¥976.65 Million | CN¥501.49 Million | ▼ -32.4% |
| 2019 | 3.63x | CN¥1.16 Billion | CN¥831.73 Million | CN¥318.92 Million | ▲ +1.1% |
| 2018 | 3.59x | CN¥986.83 Million | CN¥701.97 Million | CN¥274.52 Million | ▲ +28.2% |
| 2017 | 2.80x | CN¥701.24 Million | CN¥524.73 Million | CN¥250.00 Million | ▼ -4.0% |
| 2016 | 2.92x | CN¥542.84 Million | CN¥486.81 Million | CN¥185.75 Million | ▼ -14.2% |
| 2015 | 3.40x | CN¥425.42 Million | CN¥305.93 Million | CN¥124.94 Million | ▲ +20.0% |
| 2014 | 2.84x | CN¥382.68 Million | CN¥253.47 Million | CN¥134.92 Million | ▲ +63.5% |
| 2013 | 1.74x | CN¥281.28 Million | CN¥138.33 Million | CN¥162.12 Million | ▲ +65.4% |
| 2012 | 1.05x | CN¥68.10 Million | CN¥55.80 Million | CN¥64.93 Million | — |